Gilead Sciences, Inc. (0QYQ)
LSE
Closed
Oct 7, 2026
Day's Range
143.0052 wk Range
112.62Overview - 0QYQ - Gilead Sciences, Inc.
Key Statistics
Valuation
Enterprise Value
115.75B
P/E (Trailing)
‪34.36‬
PEG Ratio
‪-0.05‬
Price / Sales (TTM)
‪6.80‬
Price / Book
‪8.81‬
EV / EBITDA
‪9.51‬
Profitability
Gross Margin
‪79.76%‬
Profit Margin
‪20.02%‬
Operating Margin
‪35.75%‬
Return on Assets
‪9.77%‬
Return on Equity
‪26.34%‬
Ownership
Shares Outstanding
1.24B
Float
1.24B
Held by Insiders
‪0.10%‬
Held by Institutions
‪86.84%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪141.33‬
200-Day Avg
‪136.29‬
Dividends
Payout Ratio
‪68.05%‬
Frequency
Quarterly
Market Cap - 0QYQ - Gilead Sciences, Inc.
Peers - 0QYQ - Gilead Sciences, Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
- 0QYQLSEGilead Sciences, Inc.186.27BMarket Cap+24.82%52-week change34.37P/E (Trailing)‪20.02%‬Profit Margin
- AZNLSEAstraZeneca PLC19.27TMarket Cap+9.73%52-week change24.57P/E (Trailing)‪17.02%‬Profit Margin
- GSKLSEGSK plc7.52TMarket Cap+19.52%52-week change16.10P/E (Trailing)‪14.52%‬Profit Margin
- SANLSESantander UK Plc Preferred Stock 10.375% Perpetual4.72TMarket Cap+98.91%52-week change0.38P/E (Trailing)‪19.73%‬Profit Margin
- 0QIULSENovo Nordisk A/S1.06TMarket Cap-37.73%52-week change17.11P/E (Trailing)‪33.39%‬Profit Margin
- 0Q1GLSEEli Lilly and Company984.08BMarket Cap+26.67%52-week change1.49P/E (Trailing)‪33.52%‬Profit Margin
- 0QCVLSEAbbVie Inc.476.72BMarket Cap+16.79%52-week change54.53P/E (Trailing)‪15.50%‬Profit Margin
Profile Summary - 0QYQ - Gilead Sciences, Inc.
About
Gilead Sciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious diseases with unmet medical needs. Gilead Sciences specializes in therapeutic areas including HIV, viral hepatitis, oncology, inflammation, respiratory conditions, and cardiovascular…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
